Dr. Ursula Matulonis began building the gynecologic oncology team at the Dana-Farber Cancer Institute in 2004, and the program continues to grow at a remarkable rate. In 2011, six medical oncologists and five gynecologic oncology surgeons saw more than 3,700 patients. Since 2008, fifteen clinical trials in recurrent ovarian cancer have been completed and closed, and there are currently eight open clinical trials for recurrent ovarian cancer. Every member of the Dana-Farber Gynecologic Oncology Program is dedicated to contributing to the advancement of ground-breaking research for gynecological cancer patients, and they are making progress every day towards eradicating gynecologic malignancies.
This blog has been created in an effort to raise awareness, and offer information & support for the approximately 71, 000 women who receive a diagnosis of a gynecologic cancer every year, and for the people who love and care for them.
No comments:
Post a Comment